We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.55%
10 Year Est. Return
+237.03%
AUM
$919M
AUM Growth
+$75.3M
Cap. Flow
+$20.3M
Cap. Flow %
2.21%
Top 10 Hldgs %
50.96%
Holding
1,067
New
144
Increased
144
Reduced
290
Closed
83

Sector Composition

Rank Sector Weight
1 Technology 14.41%
2 Consumer Discretionary 8.23%
3 Financials 7.7%
4 Communication Services 3.69%
5 Energy 2.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DG icon
426
Dollar General
DG
$27.9B
$29K ﹤0.01%
138
DLTR icon
427
Dollar Tree
DLTR
$25.2B
$29K ﹤0.01%
320
-3,000
-90% -$282K
LNC icon
428
Lincoln National
LNC
$8.81B
$29K ﹤0.01%
+929
New +$33.2K
RWO icon
429
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
$29K ﹤0.01%
739
SE icon
430
Sea Limited
SE
$69.5B
$29K ﹤0.01%
190
+10
+6% +$1.35K
SITM icon
431
SiTime
SITM
$21.8B
$29K ﹤0.01%
+350
New +$21.8K
SRPT icon
432
Sarepta Therapeutics
SRPT
$1.77B
$29K ﹤0.01%
204
+149
+271% +$22.6K
SI
433
DELISTED
Silvergate Capital Corporation
SI
$29K ﹤0.01%
2,000
+1,500
+300% +$21.5K
AZN icon
434
AstraZeneca
AZN
$250B
$28K ﹤0.01%
255
FOXA icon
435
Fox Class A
FOXA
$26.9B
$28K ﹤0.01%
990
IR icon
436
Ingersoll Rand
IR
$33.7B
$28K ﹤0.01%
794
RSI icon
437
Rush Street Interactive
RSI
$2.88B
$28K ﹤0.01%
+2,180
New +$24.8K
NAVB
438
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$28K ﹤0.01%
10,050
CBOE icon
439
Cboe Global Markets
CBOE
$29.9B
$27K ﹤0.01%
310
CTRE icon
440
CareTrust REIT
CTRE
$9.74B
$26K ﹤0.01%
1,463
HBI
441
DELISTED
Hanesbrands
HBI
$26K ﹤0.01%
1,644
MDT icon
442
Medtronic
MDT
$112B
$26K ﹤0.01%
244
+1
+0.4% +$100
MNSB icon
443
MainStreet Bancshares
MNSB
$172M
$26K ﹤0.01%
2,100
PFFD icon
444
Global X US Preferred ETF
PFFD
$2.17B
$26K ﹤0.01%
1,010
-20,950
-95% -$513K
ZBH icon
445
Zimmer Biomet
ZBH
$18.4B
$26K ﹤0.01%
196
TCF
446
DELISTED
TCF Financial Corporation Common Stock
TCF
$26K ﹤0.01%
1,105
-13
-1% -$348
CCI icon
447
Crown Castle
CCI
$32.2B
$25K ﹤0.01%
150
-506
-77% -$83.5K
CERS icon
448
Cerus
CERS
$474M
$25K ﹤0.01%
4,000
SMMD icon
449
iShares Russell 2500 ETF
SMMD
$3.71B
$25K ﹤0.01%
565
+1
+0.2% +$45
MAXR
450
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$25K ﹤0.01%
1,006
+221
+28% +$4.89K

Similar funds

Pathstone Family Office's Q3 2020 Portfolio in Review

As of Q3 2020, Pathstone Family Office held 1,067 positions worth $919M, up 8.9% from $844M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Pathstone Family Office's Q3 2020 filing shows 144 new, 144 increased, 290 reduced and 83 closed positions. Its largest new stake was Loral Space and Communications, Inc.: 127,617 shares worth $2.33M. The largest sale was State Street SPDR MSCI ACWI ex-US ETF, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Pathstone Family Office's largest Q3 2020 buy was Loral Space and Communications, Inc.: 127,617 shares worth $2.33M.
  • Pathstone Family Office added most to iShares Core MSCI EAFE ETF in Q3 2020, an estimated $14.4M increase.
  • Pathstone Family Office's biggest Q3 2020 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $6.56M.
  • Pathstone Family Office fully exited State Street SPDR MSCI ACWI ex-US ETF in Q3 2020, selling an estimated $17.6M.
  • Pathstone Family Office's ten largest holdings make up 51% of its $919M portfolio in Q3 2020.
  • Pathstone Family Office opened 144 new positions and closed 83 in Q3 2020.
  • Pathstone Family Office's portfolio value rose 8.9% quarter-over-quarter to $919M.

Based on Pathstone Family Office's 13F filing for Q3 2020, filed 12 Nov 2020.